Matthew A. Spear Poseida Therapeutics, Inc. (PSTX) insider trading activity

Matthew A. Spear is Chief Medical Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 111,485 shares of PSTX, which is worth approximately $1.05 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K

0% 3M change

0% 12M change

Total Value Held $1.05 Million

Matthew A. Spear Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2022	BUY Grant, award, or other acquisition	-	50,000 Added 30.96%	111,485 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$13,200 $1.32 p/Share	10,000 Added 13.99%	61,485 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	$13,200 $1.32 p/Share	10,000 Added 16.26%	51,485 Common Stock
Aug 20 2021	SELL Open market or private sale	$35,160 $8.79 p/Share	4,000 Reduced 8.79%	41,485 Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	$5,280 $1.32 p/Share	4,000 Added 8.08%	45,485 Common Stock
Jul 28 2021	BUY Exercise of conversion of derivative security	$26,400 $1.32 p/Share	20,000 Added 32.53%	41,485 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$6,600 $1.32 p/Share	5,000 Added 18.88%	21,485 Common Stock
Jun 11 2021	SELL Open market or private sale	$37,760 $9.44 p/Share	4,000 Reduced 19.53%	16,485 Common Stock
Jun 11 2021	BUY Exercise of conversion of derivative security	$5,280 $1.32 p/Share	4,000 Added 16.34%	20,485 Common Stock
Apr 23 2021	BUY Exercise of conversion of derivative security	$6,600 $1.32 p/Share	5,000 Added 23.27%	16,485 Common Stock
Apr 21 2021	SELL Open market or private sale	$33,760 $8.44 p/Share	4,000 Reduced 25.83%	11,485 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$5,280 $1.32 p/Share	4,000 Added 20.53%	15,485 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$9,984 $1.32 p/Share	7,564 Added 39.71%	11,485 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	$5,176 $1.32 p/Share	3,921 Added 50.0%	3,921 Common Stock

MAS

Matthew A. Spear

Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Value

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX

Account